Farmakoterapie dyslipidémie
Dyslipidemia (DLP) represents one of the most significant risk factors of atherosclerosis. Results of many clinical studies proved that effective treatment of dyslipidemia markedly decreases cardiovascular risk. Hypolipidemic treatment becomes one of the most effective treatment options (modalities)...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Dissertation |
| Language: | Czech |
| Published: |
2009
|
| Online Access: | http://www.nusl.cz/ntk/nusl-278927 |